Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
Reata Pharmaceuticals (United States) · Renal Associates P. A. · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
700
total citations
- FWCI
- 21.39
- Percentile
- 100%
- References
- 145
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- Oxidative stress
- Inflammation
- Kidney disease
- Transcription factor
- Medicine
- Disease
- Kidney
- Immunology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.